Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline in Early Parkinson's Disease (ADAGIO)
NCT00256204Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Nov 2005
- Primary completion
- Apr 2008
- Modality
- Irreversible Covalent Inhibitors
01
Overview
A Phase 3 trial of rasagiline in Parkinson's disease (PD), sponsored by Teva Pharmaceutical Industries Ltd.. Started Nov 2005; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00256204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256204.